ClinicalTrials.Veeva

Menu

A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer (TRIPTOCARE LT)

Ipsen logo

Ipsen

Status

Completed

Conditions

Advanced Prostate Cancer

Study type

Observational

Funder types

Industry

Identifiers

NCT01383863
8-79-52014-187

Details and patient eligibility

About

The purpose of the protocol is to assess the rate of castration resistance, disease progression and overall survival over a 3-year period post-androgen deprivation therapy (ADT) induction in a study cohort of patients with advanced disease.

Enrollment

180 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have participated and received study treatment in the Triptocare study
  • Be aware of the investigational nature of this observational study cohort and must give written (personally signed and dated) informed consent

Exclusion criteria

  • Absence of written informed consent from the patient

Trial contacts and locations

35

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems